SF 4940 — Coverage of medical services and prescription medications requirement for the treatment of dementia
Last action — Author added
Write to your legislator about it: a free email template →
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced April 07, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Summary
Relating to health insurance; requiring coverage of medical services and prescription medications for the treatment of dementia; modifying step therapy requirements for medical assistance.
In the bill's own words, from its opening clause.
Bill Text
- Introduced Introduction Current html March 26, 2026
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
The bill mandates health plan coverage for medical services and medications for dementia treatment and modifies prior authorization requirements for medical assistance related to these treatments.
-
[62Q.546]
(a) A health plan company must provide coverage for every (1) type of medical service, and (2) prescription medication approved by the United States Food and Drug Administration that is used to treat or slow the progression of dementia. A health plan company must provide coverage for diagnostic testing to determine the appropriateness or effectiveness of a medical service or prescription medication to treat or slow the progression of dementia.
New coverage requirements for health plans to include dementia treatments and diagnostic testing.
-
[62Q.546]
(b) A health plan company is prohibited from using step therapy protocol, as defined in section 62Q.184, subdivision 1, when providing the coverage required under paragraph (a).
Prohibits health plans from implementing step therapy protocols for dementia treatments.
-
256B.0625, subdivision 13f
The Formulary Committee shall review and recommend drugs which require prior authorization.→ The Formulary Committee shall review and recommend drugs which require prior authorization, except those required under section 62Q.546.Exempts drugs for dementia treatment from prior authorization requirements.
Action History
-
Author added
-
Referred to Commerce and Consumer Protection
-
Introduction and first reading
Sponsors
- Johnson Stewart · Primary
- Liz Boldon · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 1 co-sponsors · 202 not signed on
Sponsors (1)
Co-sponsors (1)
- Liz Boldon Democratic-Farmer-Labor
Not signed on (202)
202 members have not signed on to this bill.
Show all 202 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Committees
- Senate Commerce and Consumer Protection Referred April 07, 2026
Subjects
Frequently asked questions
- What does SF 4940 do?
- Relating to health insurance; requiring coverage of medical services and prescription medications for the treatment of dementia; modifying step therapy requirements for medical assistance.
- Who sponsors SF 4940?
- SF 4940 is sponsored by Johnson Stewart and Liz Boldon (Democratic-Farmer-Labor).
- What is the current status of SF 4940?
- This bill is in committee in the Senate. Introduced April 07, 2026. It must pass committee before a floor vote.
- Where can I track SF 4940?
- Track SF 4940 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SF 4940
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SF 4940
Last checked for changes 18 days ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →